Clinical Trials Directory

Trials / Completed

CompletedNCT03294018

Heart Rate Changes Following the Administration of Sugammadex

Status
Completed
Phase
Study type
Observational
Enrollment
276 (actual)
Sponsor
Joseph D. Tobias · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This a prospective study when the clinician decides to use sugammadex, heart rate will be recorded every minute for 15 minutes following its administration. If bradycardia occurs and a clinical decision is made to treat it, the medications and doses used will be recorded.

Conditions

Interventions

TypeNameDescription
OTHERRecording heart rate changesRecording heart rate changes during planned sugammadex administration.

Timeline

Start date
2017-09-06
Primary completion
2019-01-10
Completion
2019-01-10
First posted
2017-09-26
Last updated
2019-10-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03294018. Inclusion in this directory is not an endorsement.

Heart Rate Changes Following the Administration of Sugammadex (NCT03294018) · Clinical Trials Directory